Findings that shed new light on the possible pathogenesis of a disease or an adverse effect

CASE REPORT

Plasmablastic multiple myeloma following clear cell renal cell carcinoma Somanath Padhi,1 Sudhagar Mokkappan,2 Renu G’ Boy Varghese,1 Ilangovan Veerappan3 1

Department of Pathology, Pondicherry Institute of Medical Sciences, Pondicherry, India 2 Department of General Medicine, Pondicherry Institute of Medical Sciences, Pondicherry, India 3 Department of Nephrology, Pondicherry Institute of Medical Sciences, Pondicherry, India Correspondence to Dr Somanath Padhi, [email protected]

SUMMARY We aim to describe the clinicohaematological profile of an elderly male with plasmablastic multiple myeloma (MM) (IgG λ, International System Stage II) with an unfavourable outcome following chemotherapy. The serum interleukin-6 level was found to be markedly elevated (2464 pg/mL, reference;

Plasmablastic multiple myeloma following clear cell renal cell carcinoma.

We aim to describe the clinicohaematological profile of an elderly male with plasmablastic multiple myeloma (MM) (IgG λ, International System Stage II...
5MB Sizes 1 Downloads 6 Views